Only 2 per cent of people opting out of electronic health record
About one in every 50 people involved in pilot trials of the My Health Record on Australia's east coast have elected to opt-out.
This is consistent with the experience elsewhere in the world, the health department says.
Some 971,000 people in the two opt-out trial areas in northern Queensland and NSW's Nepean-Blue Mountains region got access to their newly created records last week, a spokeswoman confirmed.
About 1.9% of people in both trial sites have chosen to opt out, she said.
Registered healthcare providers within the 2 primary health networks will be able to access their patients' records and upload documents from July 15.
If the trials work, a wider rollout is anticipated for 2017.
Health minister Sussan Ley announced the switch from opt-in to opt-out last October – and announced the 2 trials soon after.
She said the new system would be better for patients and cut down on unnecessary “risks and inefficiencies” that were frustrating doctors.
The AMA and RACGP remain unconvinced and say the My Health Record remains riddled with deficiencies that should be rectified before any major rollout.
They're especially concerned about the extent of patient access and the amount of upload data needed for GPs to claim eHealth incentive payments.
Last Reviewed: 21/06/2016
Reproduced with kind permission from Medical Observer.
Find out what`s involved if you take part in a clinical trial of a new medicine.
Video: Medicinal cannabis in Australia
Medicinal cannabis is now available in Australia for some conditions. Dr Norman Swan introduces medical experts who are prescribing medicinal cannabis in Australia and 2 patients who are taking medicinal cannabis.
Medicinal cannabis: Professor Chye extended interview
Professor Richard Chye, Director of the Sacred Heart Hospice and Palliative Care at St Vincent's Hospital Sydney, talks about medicinal cannabis, the dangers of unregulated cannabis products, and where medicinal cannabis is most effective.
Medicinal cannabis: Professor Scheffer extended interview
Professor Ingrid Scheffer, paediatric neurologist, discusses the use of medicinal cannabis in children with severe epilepsy, outlining which types of epilepsy medicinal cannabis is most useful for, and the possible side effects.
Zinc shortens the length of a cold
Zinc has been shown to reduce the length of symptoms of the common cold in analysis of 3 trials. People who took zinc acetate lozenges had colds that were around 2 to 3 days shorter on average.